Fluvirin
Biological
Seqirus USA Inc
Total Payments
$267,310
Transactions
3
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $267,310 | 3 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $267,310 | 3 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Adjuvanted influenza Vaccination and Morbidity and Mortaliy in US Nursing Homes | Seqirus USA Inc | $267,310 | 0 |
Top Doctors Receiving Payments for Fluvirin
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Norfolk, VA | $267,310 | 3 |
Ad
Manufacturing Companies
- Seqirus USA Inc $267,310
Product Information
- Type Biological
- Total Payments $267,310
- Total Doctors 0
- Transactions 3
About Fluvirin
Fluvirin is a biological associated with $267,310 in payments to 0 healthcare providers, recorded across 3 transactions in the CMS Open Payments database. The primary manufacturer is Seqirus USA Inc.
Payment data is available from 2018 to 2018. In 2018, $267,310 was paid across 3 transactions to 0 doctors.
The most common payment nature for Fluvirin is "Unspecified" ($267,310, 100.0% of total).
Fluvirin is associated with 1 research study, including "Adjuvanted influenza Vaccination and Morbidity and Mortaliy in US Nursing Homes" ($267,310).